TFC Financial Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
TFC Financial Management's NVO Position: Q2 2026 in Review
TFC Financial Management reduced its Novo Nordisk (NVO) stake by 47% in Q2 2026, selling an estimated $60.7K and leaving 1,619 shares worth $77.6K. The position accounts for 0.01% of the portfolio, ranked #247.
TFC Financial Management first reported a position in NVO in Q3 2020 and has held it in 24 quarters since. The position peaked at $578K in Q1 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- TFC Financial Management held 1,619 shares of Novo Nordisk worth $77.6K as of Q2 2026.
- TFC Financial Management sold 1,412 Novo Nordisk shares in Q2 2026, an estimated $60.7K.
- Novo Nordisk made up 0.01% of TFC Financial Management's portfolio in Q2 2026, its #247 holding.
- TFC Financial Management first reported a position in Novo Nordisk in Q3 2020 and has held it in 24 quarters since.
- TFC Financial Management's Novo Nordisk position peaked at $578K in Q1 2023.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.